BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,251,036 | +69.6% | 176,700 | +66.7% | 0.00% | 0.0% |
| Q2 2023 | $737,760 | +61074.1% | 106,000 | -26.2% | 0.00% | 0.0% |
| Q1 2023 | $1,206 | -100.0% | 143,625 | -45.1% | 0.00% | -80.0% |
| Q3 2022 | $3,236,000 | +42.7% | 261,800 | +24.8% | 0.01% | +25.0% |
| Q2 2022 | $2,268,000 | -52.9% | 209,800 | -28.4% | 0.00% | -42.9% |
| Q1 2022 | $4,814,000 | -9.4% | 292,889 | -20.7% | 0.01% | 0.0% |
| Q3 2021 | $5,311,000 | +2.0% | 369,355 | +9.9% | 0.01% | -22.2% |
| Q2 2021 | $5,207,000 | +133.9% | 336,100 | +50.8% | 0.01% | +200.0% |
| Q1 2021 | $2,226,000 | +56.3% | 222,902 | +17.4% | 0.00% | 0.0% |
| Q4 2020 | $1,424,000 | +260.5% | 189,880 | +84.5% | 0.00% | – |
| Q3 2020 | $395,000 | -29.6% | 102,942 | -8.7% | 0.00% | -100.0% |
| Q2 2020 | $561,000 | +120.9% | 112,715 | -11.8% | 0.00% | – |
| Q1 2020 | $254,000 | -18.1% | 127,803 | +33.1% | 0.00% | – |
| Q4 2019 | $310,000 | +252.3% | 96,051 | +246.8% | 0.00% | – |
| Q3 2019 | $88,000 | -84.1% | 27,700 | -81.1% | 0.00% | -100.0% |
| Q2 2019 | $555,000 | +0.7% | 146,532 | +109.3% | 0.00% | 0.0% |
| Q4 2018 | $551,000 | +28.7% | 70,001 | +24.7% | 0.00% | – |
| Q3 2018 | $428,000 | -32.1% | 56,126 | -53.3% | 0.00% | -100.0% |
| Q3 2017 | $630,000 | -42.9% | 120,180 | -9.4% | 0.00% | -66.7% |
| Q1 2017 | $1,103,000 | -29.3% | 132,605 | -46.2% | 0.01% | -14.3% |
| Q4 2016 | $1,561,000 | +31.2% | 246,541 | -7.8% | 0.01% | +16.7% |
| Q3 2016 | $1,190,000 | – | 267,325 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |